A bibliometric analysis of <italic>angelica sinensis</italic> (Danggui) from 2009 to 2024

<x>Abstract</x> <sec> <title>Objective:</title> <italic>Angelica sinensis</italic>, a traditional Chinese herbal medicine, boasts rich history and diverse pharmacological effects, influencing the hematopoietic system, circulatory system, and immune system. This study conducted a bibliometric analysis of <italic>angelica sinensis</italic> literature over the past 15 years to identify research hotspots and gaps. </sec> <sec> <title>Methods:</title> Utilizing the Web of Science Core Collection (WoSCC), data was analyzed through VOSviewer and Excel, with polynomial regression assessing annual publication trends. Through co-citation analysis, keyword co-occurrence and bibliographic coupling, this study uncovered distinct knowledge structures and dynamics within <italic>agelica</italic> research, offering profound understanding of current research priorities and trends. </sec> <sec> <title>Results:</title> The study revealed a significant annual increase in publications on <italic>angelica sinensis</italic>. Over the past 15 years, 1,588 articles by 7,960 authors from 53 countries and 1,355 organizations have been published. China demonstrated notable productivity and influence in this field. <italic>Angelica</italic> polysaccharide and Z-ligustilide emerged as the most studied active ingredients. <italic>Angelica sinensis</italic> demonstrated protective effects against apoptosis and oxidative stress-induced cell damage, with its anti-inflammatory properties becoming a focal point of recent research. The classical prescription “Danggui Buxue decoction” was extensively studied for its hematopoietic, anti-tumor effects, and ability to stabilize human iron balance and ameliorate depression. Furthermore, research on <italic>angelica sinensis</italic> has spanned multiple disciplinary areas, including pharmacology, medicinal chemistry, complementary medicine and plant sciences. </sec> <sec> <title>Conclusions:</title> As a pivotal gynecological drug, <italic>angelica sinensis</italic> has been the focus of extensive research endeavors over the past 15 years, yielding comprehensive fundamental studies and diverse clinical applications in hematopoiesis, immunity, and other related fields. </sec>